---
figid: PMC9697024__pharmaceuticals-15-01442-g005
pmcid: PMC9697024
image_filename: pharmaceuticals-15-01442-g005.jpg
figure_link: /pmc/articles/PMC9697024/figure/pharmaceuticals-15-01442-f005/
number: Figure 5
figure_title: ''
caption: 'Apigenin decreases liver XOD levels (A; U/g, n =10) and renal expression
  levels of GLUT9 and URAT1, and increases renal expression levels of OAT1 in HUA
  mice. Representative images of western blot and their analyses show GLUT9 (B), URAT1
  (C), and OAT1 (D) expressions in the kidneys (n â‰¥ 3). ##p < 0.01, #p < 0.05 vs.
  the NC group. ** p < 0.01, * p < 0.05 vs. the HC group.'
article_title: Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation
  of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway.
citation: Tianyuan Liu, et al. Pharmaceuticals (Basel). 2022 Nov;15(11):1442.
year: '2022'

doi: 10.3390/ph15111442
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- hyperuricemia
- apigenin
- uric acid
- molecular docking
- JAK2/STAT3 signaling
- renal injury

---
